These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18234506)

  • 1. Elevated manganese levels in blood and CNS in human prion disease.
    Hesketh S; Sassoon J; Knight R; Brown DR
    Mol Cell Neurosci; 2008 Mar; 37(3):590-8. PubMed ID: 18234506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated manganese levels in blood and central nervous system occur before onset of clinical signs in scrapie and bovine spongiform encephalopathy.
    Hesketh S; Sassoon J; Knight R; Hopkins J; Brown DR
    J Anim Sci; 2007 Jun; 85(6):1596-609. PubMed ID: 17296770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies.
    Beekes M; McBride PA
    FEBS J; 2007 Feb; 274(3):588-605. PubMed ID: 17288548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions and manganese: A maddening beast.
    Brown DR
    Metallomics; 2011 Mar; 3(3):229-38. PubMed ID: 21390367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion proteins: physiological functions and role in neurological disorders.
    Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
    J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases.
    Liberski PP; Sikorska B; Hauw JJ; Kopp N; Streichenberger N; Giraud P; Budka H; Boellaard JW; Brown P
    Virus Res; 2008 Mar; 132(1-2):226-8. PubMed ID: 18164506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of prion protein expression on metal metabolism.
    Kralovicova S; Fontaine SN; Alderton A; Alderman J; Ragnarsdottir KV; Collins SJ; Brown DR
    Mol Cell Neurosci; 2009 Jun; 41(2):135-47. PubMed ID: 19233277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative damage to nucleic acids in human prion disease.
    Guentchev M; Siedlak SL; Jarius C; Tagliavini F; Castellani RJ; Perry G; Smith MA; Budka H
    Neurobiol Dis; 2002 Apr; 9(3):275-81. PubMed ID: 11950273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases.
    Minghetti L; Pocchiari M
    Int Rev Neurobiol; 2007; 82():265-75. PubMed ID: 17678966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1152-4. PubMed ID: 18946463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creutzfeldt-Jakob disease: an emergency department presentation of a rare disease.
    Prince LA; Mann D; Reilly T
    J Emerg Med; 2006 Jul; 31(1):41-4. PubMed ID: 16798153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural pathology of prion diseases revisited: brain biopsy studies.
    Liberski PP; Streichenberger N; Giraud P; Soutrenon M; Meyronnet D; Sikorska B; Kopp N
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):88-96. PubMed ID: 15634235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse models of prion diseases.
    Telling GC
    Methods Mol Biol; 2008; 459():249-63. PubMed ID: 18576160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific particles without prion protein in prion diseases - phenomenon or epiphenomenon?
    Liberski PP; Brown P
    Neuropathol Appl Neurobiol; 2007 Aug; 33(4):395-7. PubMed ID: 17617871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
    Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
    J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased brain copper due to copper deficiency has no effect on bovine prion proteins.
    Legleiter LR; Ahola JK; Engle TE; Spears JW
    Biochem Biophys Res Commun; 2007 Jan; 352(4):884-8. PubMed ID: 17157816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal function and morphology are altered in cattle infected with the prion disease transmissible mink encephalopathy.
    Smith JD; Greenlee JJ; Hamir AN; Richt JA; Greenlee MH
    Vet Pathol; 2009 Sep; 46(5):810-8. PubMed ID: 19429980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function.
    Gressner OA; Schifflers MC; Kim P; Heuts L; Lahme B; Gressner AM
    Clin Chim Acta; 2009 Feb; 400(1-2):86-90. PubMed ID: 19000909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
    Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
    Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
    Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.